This section explores potential combination treatments and how they can be utilized in clinical practice to optimize weight loss outcomes
Kidney protection Semaglutide helps protect the kidneys in people with type 2 diabetes and kidney disease by slowing down kidney function decline and reducing the risk of serious kidney problems
has acted as consultant, advisory board member and speaker for Boehringer Ingelheim, Eli Lilly, Novo Nordisk and Sanofi, an advisory board member Lexicon, Pfizer, ShouTi Pharma Inc, AstraZeneca and Medtronic and as a speaker for AstraZeneca, Napp Pharmaceuticals, Novartis and Amgen
470 In this trial, semaglutide benefited patients with heart failure and preserved ejection fraction by intervening with upstream metabolic drivers
This dose is often where the most significant metabolic shifts occur
Gastrointestinal symptoms are the most common side-effect category